REQUEST A DEMO
Total
USD $0.00
Search more companies

Colmenares Lucena Luis Francisco (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Colmenares Lucena Luis Francisco Profile Updated: September 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Colmenares Lucena Luis Francisco is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Pharmacies and Drug Stores industry. It was incorporated on October 11, 1991. The total number of employees is currently 2 (2025). There was a net sales revenue increase of 219.23% reported in Colmenares Lucena Luis Francisco’s latest financial highlights for 2024. Its total assets decreased by 40.3% over the same period. In, 2024, the company’s net profit margin increased by 6.01%.

Headquarters
Cr. 31 # 54 - 29
Bucaramanga; Santander;

Contact Details: Purchase the Colmenares Lucena Luis Francisco report to view the information.

Basic Information
Total Employees:
Purchase the Colmenares Lucena Luis Francisco report to view the information.
Financial Auditors:
Purchase the Colmenares Lucena Luis Francisco report to view the information.
Incorporation Date:
October 11, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Colmenares Lucena Luis Francisco report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
219.23%
Total operating revenue
219.23%
Net Profit (Loss) for the Period
687.47%
Total assets
-40.3%
Total equity
-45.21%
Net Profit Margin
6.01%
Return on Equity (ROE)
32.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?